An autoinjector or autoinjector is a medical device that is primarily designed to deliver a dose of a particular drug. The injectors were mainly built to overcome the hesitation associated with self-administration of the needle-based drug delivery device. Most of the autoinjectors are disposable, one-use, spring-loaded syringes. In terms of design, the autoinjectors are easy to use and are planned for self-administration by the patients or administration by the untrained personnel. The site of injection mainly depends on the drug-loaded, but it typically is administered into the buttocks or the thigh.
Most disposable autoinjectors commonly use a pre-loaded spring as a prime source of power. This spring and its associated mechanical components form a one-shot linear actuator. When triggered, the actuator there drives a three-step sequence: accelerate the syringe forward, puncture the injection site, actuate the piston of the syringe, inject the drug, and deploy a shield to cover the needle. Some injectors are mainly triggered by pushing the nose ring against the injection site and simultaneously, while applying pressure, pushing a trigger button at the rear end of the device. Other designs utilize a safety mechanism similar to nail guns.
In the year 2020, the global autoinjectors market size was around 46.0 billion US dollars. It is forecasted that by the year 2030 global autoinjectors market will reach a landmark of about 238.7 billion US dollars with a CAGR of 17.9% throughout the forecasted period. The Autoinjectors Market is in a growing phase, which is mainly due to the expanded utilization of adrenaline, food allergens, EpiPen autoinjector, autoinjector pen, autoinjector syringes, and anaphylaxis. In addition, the health care providers utilize autoinjectors mainly because of their benefits, like accurate drug dosage, minimizing phobias related to the needle, and many others.
The Increased occurrence of anaphylaxis is a significant reason behind the growth of autoinjectors market size. Anaphylaxis is a disorder wherein the patients usually suffer from a dangerous allergic reaction which can be even life-threatening, caused due to drugs, latex, food, and Hymenoptera stings. An adrenaline autoinjector is mainly used to cure anaphylaxis. Anaphylaxis is a very common case in every one causality found in every 1000 cases, as reported by NICE studies. The European Journal of Allergy and Clinical Immunology 2019 studies reported that globally there is a significant variation with respective children affected by anaphylaxis.
Recent Developments related to Global Autoinjectors Market
- On the 17th of December, 2021, a strategic partnership between Eversana and Experic occurred that aims for the development of commercialization and optimizing the manufacturing process. The key objective behind this strategic partnership was to eradicate the inabilities present within the entire traditional industry. With the help of this partnership, both the companies can serve more than around 600 pharmaceutical companies and new start-ups.
- In the month of August 2020, Saudi Arabia's supply and regulatory approval body XYOSTED enabled collaboration between Antares Pharma and Lunatus Global. According to the agreement, Antares Pharma will take care of the packaging and manufacturing units, while Lunatus Global will take care of getting approvals, promotion, and distribution systems.